Copyright
©The Author(s) 2022.
World J Gastroenterol. Aug 28, 2022; 28(32): 4620-4634
Published online Aug 28, 2022. doi: 10.3748/wjg.v28.i32.4620
Published online Aug 28, 2022. doi: 10.3748/wjg.v28.i32.4620
No. | Group | Creatinine, mmol/L | Urea,mmol/L | Uric acid, mmol/L | AKT, U/L | AST, U/L | ALT, U/L | GGT, U/L | Total protein, g/L | Albumin, g/L | Globulin, g/L | Albumin/ Globulin ratio | Total Bilirubin, µmol/L | Na | K | CL |
1 | Untreated | 28.1 ± 1.5 | 8.80 ± 0.9 | 0.20 ± 0.0 | 96.0 ± 0.5 | 195 ± 0.7 | 73.0 ± 0.7 | < 3.0 ± 0.0 | 50.0 ± 0.5 | 30.0 ± 1.1 | 23.0 ± 0.5 | 1.40 ± 0.3 | < 2.0 ± 0.0 | 178 ± 0.3 | 8.00 ± 0.7 | 124 ± 1.1 |
2 | Gemcitabine (10 mg/kg per 3 d) | 28.0 ± 1.9 | 9.00 ± 1.1 | 0.16 ± 0.1 | 93.0 ± 1.1 | 190 ± 0.9 | 72.0 ± 0.9 | < 3.0 ± 0.0 | 52.0 ± 1.2 | 32.0 ± 0.7 | 24.0 ± 0.7 | 1.40 ± 0.2 | < 2.0 ± 0.0 | 173 ± 0.5 | 9.30 ± 0.4 | 123 ± 0.2 |
3 | O.s (200 mg/kg per day) | 29.0 ± 1.5 | 9.20 ± 1.3 | 0.19 ± 0.0 | 98.0 ± 1.2 | 201 ± 1.1 | 80.0 ± 1.1 | < 3.0 ± 0.0 | 50.5 ± 0.7 | 33.0 ± 0.3 | 23.0 ± 0.7 | 1.30 ± 0.3 | < 2.0 ± 0.0 | 174 ± 0.8 | 9.00 ± 0.8 | 128 ± 0.9 |
4 | O.s (200 mg/kg per day) and gemcitabine (10 mg/kg per 3 d) combination | 27.5 ± 1.1 | 9.50 ± 0.9 | 0.21 ± 0.1 | 101 ± 0.9 | 210 ± 0.7 | 77.0 ± 0.7 | < 3.0 ± 0.0 | 51.3 ± 1.1 | 29.9 ± 0.9 | 22.5 ± 0.9 | 1.30 ± 0.2 | < 2.0 ± 0.0 | 186 ± 0.9 | 8.60 ± 0.6 | 130 ± 1.1 |
5 | O.s (400 mg/kg per day) | 28.5 ± 0.9 | 8.80 ± 0.7 | 0.22 ± 0.1 | 101 ± 0.7 | 199 ± 0.9 | 66.0 ± 0.5 | < 3.0 ± 0.0 | 51.9 ± 0.5 | 32.4 ± 0.8 | 25.0 ± 0.9 | 1.40 ± 0.2 | < 2.0 ± 0.0 | 190 ± 0.4 | 10.0 ± 0.5 | 133 ± 0.9 |
6 | O.s (400 mg/kg per day) and gemcitabine (10 mg/kg per 3 d) combination | 27.0 ± 0.8 | 8.50 ± 1.3 | 0.21 ± 0.0 | 103 ± 0.8 | 190 ± 0.7 | 70.0 ± 0.9 | < 3.0 ± 0.0 | 52.0 ± 0.7 | 30.5 ± 0.6 | 24.0 ± 0.7 | 1.40 ± 0.1 | < 2.0 ± 0.0 | 185 ± 0.6 | 9.80 ± 0.9 | 123 ± 0.5 |
- Citation: Yehya AHS, Subramaniam AV, Asif M, Kaur G, Abdul Majid AMS, Oon CE. Anti-tumour activity and toxicological studies of combination treatment of Orthosiphon stamineus and gemcitabine on pancreatic xenograft model. World J Gastroenterol 2022; 28(32): 4620-4634
- URL: https://www.wjgnet.com/1007-9327/full/v28/i32/4620.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i32.4620